Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
      • What Are Exclusions?
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (30)
  • 2025 (16)
  • 2022 (3)
  • 2021 (2)
  • 2020 (2)
  • 2019 (1)
  • 2017 (1)

Subject

  • Drug Trafficking (4236)
  • Synthetic drugs (1150)
  • Guns/Weapons (1049)
  • OCDETF/Task Force (826)
  • Fake Pills (693)
  • Arrests/Convictions - Major (659)
  • Guilty Plea (561)
  • Seizures (Drugs/Property) (491)
  • Prescription Drugs (378)
  • Overdose (329)
  • Major Law Enforcement Operation (281)
  • Diversion Division (258)
  • Take Back Day (253)
  • Task Forces/Task Force Officers (246)
  • Pharmaceuticals/Pharmacists/Physicians (230)
  • Money Laundering (219)
  • Gangs (202)
  • Outreach/Drug Prevention (190)
  • Fentanyl Awareness (169)
  • One Pill Can Kill (120)
  • HIDTA (105)
  • Press Conferences (69)
  • Narcoterrorism (55)
  • Extraditions (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Public and Media Affairs - also see Congressional Affairs (52)
  • Counterfeit Pills (44)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Campaigns (14)
  • Other (14)
  • Terrorism (14)
  • Critical Incident (10)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Fentanyl Free America (46)

Drug Name

  • Fentanyl (25)
  • Cocaine (11)
  • Methamphetamine (10)
  • Heroin (4)
  • Opioids (3)
  • Marijuana (Cannabis) (2)
  • Oxycodone (2)
  • Synthetic Opioids (2)
  • Benzodiazepines (1)
  • Hydromorphone (1)
  • Morphine (1)

Field Division

  • Seattle (7)
  • Washington, DC (7)
  • Houston (6)
  • Omaha (5)
  • San Francisco (4)
  • Sede (4)
  • Detroit (3)
  • New Orleans (3)
  • Los Angeles (2)
  • Louisville (2)
  • New York (2)
  • Phoenix (2)
  • Rocky Mountain (2)
  • Dallas (1)
  • Miami (1)
  • New England (1)
  • New Jersey (1)
  • San Diego (1)
  • St. Louis (1)
Clear All Results
55 Results - Showing 41 to 50
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Houston –The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to protecting...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

ST. LOUIS – The U.S. Drug Enforcement Administration (DEA) is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. Through intensified enforcement operations and...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

SEATTLE– The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to protecting...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

ARIZONA – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

DALLAS – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

San Antonio Man Sentenced to 25 Years in Federal Prison for Trafficking Fentanyl

SAN ANTONIO – A previously convicted felon was sentenced in a federal court in San Antonio to 25 years in prison for possessing nearly 10,000 fentanyl pills intended for distribution along with a firearm. According to court documents, Tyrell Ezekiel Darden, 25, of San Antonio, had two active felony arrest...
PRESS RELEASE

DEA Graduates the Sixth Annual Citizens Academy Class in Richmond, Virginia

Richmond, Va., – The United States Drug Enforcement Administration is active in many local communities through Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations, and collaboration with local partners. As part of this mission, Citizens Academies are held to connect field offices...
PRESS RELEASE

DEA Launches Second Year of Operation Engage

PHOENIX – The United States Drug Enforcement Administration (DEA) Special Agent in Charge (SAC) Cheri Oz is pleased to announce the launching of the second year of Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations and collaboration with local partners. “DEA’s priority...
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
PRESS RELEASE

Charlottesville Dermatologist Sentenced for Diverting Pain Medication

CHARLOTTESVILLE, Va., – A dermatologist formerly employed at a dermatological practice in the City of Charlottesville was sentenced last week to 12 months probation, including a period of home confinement and electronic monitoring, for using the Drug Enforcement Administration (DEA) registration number of her co-workers to obtain prescription opioid pain...

Paginación

  • Primera página «
  • Anterior
  • Página 1
  • Página 2
  • Página 3
  • Página 4
  • Current page 5
  • Página 6
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Oficinas Extranjeras
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster